Target intelligence / Profile preview

Rabies virus phosphoprotein (P), matrix protein (M), and RNA-directed RNA polymerase (L) (RABV P-M-L)

Target
RABV P-M-L
Molecular classification
Enzyme, Viral protein, RNA-directed RNA polymerase, Adaptor protein, Structural protein
01

Overview

The Rabies virus phosphoprotein (P), matrix protein (M), and RNA-directed RNA polymerase (L) are essential components of the Rabies virus (RABV) life cycle, collectively facilitating viral replication, transcription, and assembly. The L protein is the catalytic core of the RNA-dependent RNA polymerase (RdRp) complex, performing all enzymatic activities required for RNA synthesis, capping, and polyadenylation (PMID: 28724771). The P protein serves as a vital cofactor for the L protein and a chaperone for the nucleoprotein, while also acting as a major interferon antagonist that suppresses the host immune response (PMID: 16140868). The M protein is a multifunctional structural protein that regulates the balance between viral transcription and replication and mediates the budding of progeny virions from the host cell membrane (PMID: 11832466). Because these proteins are indispensable for viral survival and lack human homologs, they are prime targets for antiviral drug development. Experimental drugs such as Favipiravir target the L protein's polymerase activity to inhibit viral progression (PMID: 24954874). Therapeutic challenges include the rapid progression of the disease and the difficulty of delivering inhibitors across the blood-brain barrier to the infected neurons (PMID: 30634450).

Other names
Rabies virus P proteinRabies virus M proteinRabies virus L proteinRabies virus replication complexRABV P-M-L complexRabies virus ribonucleoprotein complex components
02

Mechanism of action

Inhibition of the RNA-dependent RNA polymerase (RdRp) complex, leading to the termination of viral RNA synthesis or the induction of lethal mutations in the viral genome (PMID: 24954874).

03

Biological functions

Viral RNA replicationViral transcriptionViral assemblyImmune evasionViral budding
04

Disease associations

InfectionRabies
05

Safety considerations

Blood-brain barrier penetrationNeurotoxicityViral resistanceRapid disease progression
06

Interacting drugs

Favipiravir

2 more in the full profile.

07

Biomarkers

Rabies virus RNA (RT-PCR)Rabies virus antigen (DFA test)Negri bodiesAnti-rabies antibodies (RFFIT)

Beyond the preview

Go deeper on Rabies virus phosphoprotein (P), matrix protein (M), and RNA-directed RNA polymerase (L) (RABV P-M-L).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rabies virus phosphoprotein (P), matrix protein (M), and RNA-directed RNA polymerase (L) (RABV P-M-L).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call